100 episodes

Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years.

DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go.

In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informatics; personalised medicine; screening; therapeutics, and much more.

For the podcast we have selected recent, relevant and popular scientific articles, so that you can listen to all of the best content from Drug Discovery World. We hope you enjoy.

The Drug Discovery World Podcast Drug Discovery World (DDW)

    • Life Sciences
    • 5.0 • 4 Ratings

Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years.

DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go.

In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informatics; personalised medicine; screening; therapeutics, and much more.

For the podcast we have selected recent, relevant and popular scientific articles, so that you can listen to all of the best content from Drug Discovery World. We hope you enjoy.

    Evolution of User Experience for life sciences

    Evolution of User Experience for life sciences

    Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centres on the behaviours and needs of users.

    The clear benefits of UX offered in the retail and consumer sectors have been slow to percolate to other more complex sectors such as the life sciences. As the benefits of adoption of UX come to be realised, we see steady and strong growth in the R&D life sciences sector.

    https://www.ddw-online.com

    • 24 min
    Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic

    Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic

    Non-alcoholic fatty liver disease (NAFLD) has quietly become one of the most common causes of chronic liver disease in the modern world. If this prevalence is allowed to continue the economic and clinical burden will reach a staggering level.

    Non-alcoholic fatty liver disease (NAFLD) consists of a complex combination of liver maladies, ranging from benign hepatic steatosis (fatty liver) to its more aggressive inflammatory manifestation, non-alcoholic steatohepatitis (NASH).

    https://www.ddw-online.com

    • 22 min
    Reducing the PAINS in High Throughput Screening: Assay design as a tool for maximising efficiency

    Reducing the PAINS in High Throughput Screening: Assay design as a tool for maximising efficiency

    This article will describe, with examples, how understanding the likely mechanisms of false positives in advance of screening informs the design of the hit triage, thus increasing the likelihood of discovering optimisable chemical matter and avoiding costly wasting of resource.

    https://www.ddw-online.com

    • 19 min
    The COVID-19 Race: how mouse models will help researchers cross the finish line

    The COVID-19 Race: how mouse models will help researchers cross the finish line

    The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe.

    Amid the worldwide health emergency created by high infection rates, rapid transmission spread and relatively high mortality rates, researchers are under pressure to understand the disease’s pathogenesis, develop and test investigational therapeutics and explore viable vaccine approaches.

    https://www.ddw-online.com

    • 20 min
    Cryo-EM accelerates drug discovery by delivering previously intractable structural insights

    Cryo-EM accelerates drug discovery by delivering previously intractable structural insights

    Cryo-electron microscopy (cryo-EM), a powerful biophysical technique that can analyse molecular assemblies, is changing the paradigm in structure-based drug design.

    As targets become more challenging, solving structures of drug target molecules or biologics becomes increasingly difficult. Cryo-EM empowers drug discovery teams to take advantage of rational drug design for many more major drug target classes.

    For more information on Drug Discovery World, head to:
    https://www.ddw-online.com

    • 17 min
    The Reality of Virtual Pharmaceutical Companies

    The Reality of Virtual Pharmaceutical Companies

    In this episode, we discuss the oxymoronic proposition of a Virtual Pharmaceutical Company (VPC) and the typical adopted business model, as well as provide examples of such companies currently trying to undertake this adventurous task.

    For more information on Drug Discovery World, head to:
    https://www.ddw-online.com

    • 30 min

Customer Reviews

5.0 out of 5
4 Ratings

4 Ratings

MicheleJSLabs ,

Really informative scientific podcast

Perfect for a variety of topics around drug discovery

AgaJ91 ,

Excellent Podcast

A really thorough informative podcast with a variation of information around drug discovery and pharma

Top Podcasts In Life Sciences

Listeners Also Subscribed To